[Federal Register Volume 68, Number 211 (Friday, October 31, 2003)]
[Notices]
[Pages 62088-62089]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-27558]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
Veterinary Medicine Advisory Committee; Amendment of Notice
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice.
-----------------------------------------------------------------------
[[Page 62089]]
The Food and Drug Administration (FDA) is announcing an amendment
to the notice of meeting of the Veterinary Medicine Advisory Committee.
This meeting was announced in the Federal Register of September 18,
2003 (68 FR 54734). The amendment is being made to reflect changes in
the Date and Time, and the Agenda, portions of the document.
Specifically, due to withdrawal of permission by a sponsor to discuss a
specific fourth generation cephalosporin on November 3, 2003, the topic
has been indefinitely postponed. Discussions on November 5, 2003,
regarding genetic engineering research with food animals have also been
postponed.
FOR FURTHER INFORMATION CONTACT: Aleta Sindelar, Center for Veterinary
Medicine (CVM) (HFV-3), Food and Drug Administration, 7519 Standish
Pl., Rockville, MD 20855, 301-827-4515, e-mail: [email protected],
or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-
0572 in the Washington, DC area), code 12546. Please call the
Information Line for up-to-date information on this meeting.
SUPPLEMENTARY INFORMATION: In the Federal Register of September 18,
2003, FDA announced that a meeting of the Veterinary Medicine Advisory
Committee will be held on November 3, 4, and 5, 2003. On page 54734, in
the second column, the Date and Time portion of the meeting is amended
to read as follows:
Date and Time: The meeting will be held on November 4, 2003, from 9
a.m. to 5 p.m.
On page 54734, in the second column, the Agenda portion of the
meeting is amended to read as follows:
Agenda: On November 4, 2003, the committee will hear a preview of a
draft risk assessment on animal cloning using somatic cell nuclear
transfer. The risk assessment addresses both animal health and
consumption of food derived from animal clones and their progeny.
Background information that includes a draft executive summary of the
risk assessment will be made available to committee members and the
public in advance of the meeting and posted on CVM's home page at
http://www.fda.gov/cvm. A limited number of paper copies of the
background information will be available at the registration table. The
complete draft risk assessment document will be made available for
public comment at a later date.
Dated: October 28, 2003.
Peter J. Pitts,
Associate Commissioner for External Relations.
[FR Doc. 03-27558 Filed 10-29-03; 1:11 pm]
BILLING CODE 4160-01-S